Every Form 4 that ZOETIS INC. (ZTS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ZTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZTS filings page.
Zoetis Inc. (ZTS) director Mark Stetter reported an acquisition of 342.3720 Phantom Stock Units on September 17, 2026 under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. Each unit represents one share of Zoetis common stock and will be settled in cash after separation from service, bringing his total Phantom Stock Units to 880.1751.
Zoetis Inc. (symbol: ZTS) is the issuer of record for a Form 4 filing submitted to the SEC. SACCARO JAMES reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. (ZTS) reported that EVP, CFO & COO James Saccaro received a compensation-related grant of 81,063 Restricted Stock Units (RSUs) on August 31, 2026. Each RSU represents a contingent right to one share of Zoetis common stock, with one-third scheduled to vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting conditions.
Zoetis Inc. director Frank A. D'Amelio reported a bona fide gift of 6,650 shares of Zoetis common stock on 2026-08-07. The shares were transferred to the Frank A. D'Amelio 2-Year 2026 GRAT No. 3, where he is grantor, trustee and beneficiary, and are now reported as indirectly held. After the gift, he directly holds 14,808 shares and the trust holds 6,650 shares.
Sarbaugh Keith reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Keith Sarbaugh received a grant of 259.6384 phantom stock units on July 10, 2026 under the Zoetis Supplemental Savings Plan. These cash-settled units track the value of Zoetis common stock and increase his total phantom stock holdings to 2364.8311 units.
PECK KRISTIN C reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Executive Officer Kristin C. Peck reported a grant of 616.0892 phantom stock units on 2026-07-10 under the Zoetis Supplemental Savings Plan at $26.2200 per unit. Each unit’s value tracks Zoetis common stock plus cash-equivalent investments and is settled in cash, bringing her balance to 66,194.8959 phantom units.
Nayak Abhay U reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Abhay U. Nayak received a compensation-related grant of 214.6155 Phantom Stock Units on 2026-07-10 under the Zoetis Supplemental Savings Plan. These cash-settled units track Zoetis common stock plus cash-equivalent investments and increase his phantom stock balance to 4,700.5887 units.
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received a grant of 308.0457 phantom stock units on July 10, 2026 under the Zoetis Supplemental Savings Plan at a reference value of $26.2200 per unit. These cash-settled units track the value of Zoetis common stock plus a small cash-equivalent component, and Esch now holds 806.4312 phantom stock units in total, representing an interest tied to 106.8946 underlying shares of Zoetis common stock.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 237.6361 phantom stock units on July 10, 2026 at a reference value of $26.2200 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 6,273.3823 units, economically corresponding to 82.4619 phantom common stock equivalents.
These phantom stock units are settled in cash after her separation from service and may be reallocated among investment funds, with Zoetis able to limit transfer timing and frequency; their value is determined by Zoetis common stock performance plus a small cash-equivalent component.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Executive Vice President Julie Fuller received a grant of 314.6453 phantom stock units on July 10, 2026 under the Zoetis Supplemental Savings Plan. These units are cash-settled based on Zoetis common stock value and cash-equivalent investments, bringing her total phantom stock unit holdings to 2112.6819.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 314.6453 phantom stock units at $26.2200 per unit under the Zoetis Supplemental Savings Plan. These cash-settled units track Zoetis common stock plus cash-equivalent investments and increase her phantom stock unit balance to 30,946.8610.
Zoetis Inc. reported that Executive Vice President Ferran Astorga Jeannette acquired 45.3272 Phantom Stock Units on 2026-07-10 under the Zoetis Supplemental Savings Plan. These units relate to 15.7289 underlying shares of common stock and bring the total phantom stock unit balance to 2296.1569. The units are settled in cash after separation from service, and their value is tied to Zoetis common stock plus cash-equivalent investments, which typically represent around 5% of each unit’s value.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported a compensation-related award of 363.0526 phantom stock units under the Zoetis Supplemental Savings Plan on July 10, 2026, at a reference value of $26.2200 per unit. These units are settled in cash after separation from service and their value is tied to Zoetis common stock plus cash-equivalent investments, which typically represent around 5% of each unit’s value. Following this credit, Wetteny holds 10,155.3554 phantom stock units directly.
Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Mark Stetter reported receiving a grant of 317.6216 phantom stock units tied to Zoetis common stock, based on a value of $78.71 per unit. These units reflect the deferral of his director cash retainer into the Zoetis stock fund and bring his total phantom stock unit balance to 534.0883. Each phantom stock unit is economically equivalent to one Zoetis common share but will be settled in cash after he separates from service, so this filing reflects non-employee director compensation rather than an open-market stock purchase or sale.
Zoetis Inc. director Michael B. McCallister reported a bona fide gift of 1,209 shares of Zoetis common stock. The shares were transferred from his direct holdings to a trust where he serves as trustee, consolidating ownership within a family trust structure.
Following the transaction, McCallister reports no directly held Zoetis shares and 31,893 shares held indirectly by the Michael and Charlene McCallister Family Trust DTD 11/14/2014. The filing shows no option exercises or sales; the activity reflects estate and account administration rather than market trading.
Zoetis Inc. director Mark Stetter acquired common stock through vesting of restricted stock units (RSUs) on May 21, 2026. He exercised RSUs to receive 1,572 shares of Zoetis common stock as equity compensation, with no open‑market sale reported in this filing.
The RSUs convert on a one‑for‑one basis into common shares upon vesting, consistent with grants under the Zoetis Amended and Restated 2013 Equity and Incentive Plan. After this event, he holds 1,572 common shares directly and retains additional RSU-based rights to Zoetis stock.
Zoetis Inc. director Louise M. Parent acquired common stock through equity award settlements rather than market trades. On May 20, 2026, she received 10,186 shares upon vesting and settlement of deferred stock units and 1,944 shares upon vesting and settlement of restricted stock units, both in connection with her retirement from the Zoetis Board of Directors. These transactions reflect the conversion of fully vested DSUs and RSUs, with no open-market buying or selling reported and no remaining derivative units shown after settlement.
Zoetis Inc. director Frank A. D'Amelio bought shares of the company in the open market. He purchased 6,650 shares of Zoetis common stock at a price of $75.39 per share in a single transaction. Following this purchase, he directly owns 21,458 shares of Zoetis common stock.
Zoetis Inc. director Paul Bisaro reported an open-market buy of Common Stock. On May 13, 2026, he purchased 2,000 shares at $75.875 per share in a single transaction. Following this purchase, his direct holdings increased to 27,862 shares of Zoetis common stock.
Zoetis Inc. director Michael B. McCallister reported an open-market purchase of 3,000 shares of Zoetis common stock. The shares were bought indirectly through a family trust at a weighted average price of $77.7578 per share, with individual trade prices ranging from $77.72 to $77.80.
After this purchase, one trust associated with McCallister holds 24,524 Zoetis shares indirectly, while separate records show 1,209 shares held directly and additional shares held through another trust for his spouse and family.
Zoetis Inc. Executive Vice President Kevin Esch reported routine equity compensation activity. On April 30, 2026, he exercised restricted stock units to acquire 259 shares of Zoetis common stock at an exercise price of $0.00 per share. To cover tax obligations, 75 shares of common stock were disposed of at $114.97 per share as a tax-withholding transaction, not an open-market sale. Following these transactions, he directly holds 578 shares of common stock and indirectly holds 124.4082 common stock equivalents in the Zoetis Savings Plan, a 401(k) plan. He also continues to hold RSUs covering 44.1900, 205.8853 and 4043.3874 underlying shares of Zoetis common stock that will vest in stages on specified future anniversaries, subject to continued service.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller received a grant of 550.6435 phantom stock units on Zoetis common stock at a reference price of $39.64 per unit. Following this award, she holds a total of 1,798.0366 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash after her separation from service and may be transferred into an alternative investment fund, subject to Zoetis’ limits on the timing, frequency and permissibility of such transfers.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 550.6436 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and the award is settled in cash after her separation from service.
The grant corresponds to 185.1986 shares of underlying Zoetis common stock for value-tracking purposes, and brings her total phantom stock unit balance to 30,632.2157 units. The units may be transferred into alternative investment funds, although Zoetis may limit the timing and frequency of such transfers.
Ferran Astorga Jeannette reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 4.997 phantom stock units on April 10, 2026. The award was made under the Zoetis Supplemental Savings Plan and increases the executive’s total phantom stock unit holdings to 2,250.8297 units.
These phantom stock units are cash-settled after the executive separates from service and may be reallocated among investment funds within plan limits. Each unit’s value is tied to the market value of Zoetis common stock plus a small cash-equivalent investment component that typically represents around 5% of the total value.
Zoetis Inc. Executive Vice President Kevin Esch reported a compensation-related grant of phantom stock units. On April 10, 2026, he acquired 1.3946 phantom stock units at a reference value of $39.64 per unit under the Zoetis Supplemental Savings Plan, bringing his total to 498.3855 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, with the value determined by Zoetis’ market price and the cash-equivalent portion. These units are settled in cash after his separation from service and can be reallocated among plan investment funds, subject to Zoetis’ transfer limitations.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received a grant of 2,776.7700 phantom stock units on Zoetis common stock, valued at $39.6400 per unit. These units were acquired under the Zoetis Supplemental Savings Plan as a compensation-related award.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s value. The units are settled in cash after her separation from service, and their value is tied to Zoetis’s share price and the associated cash-equivalent investments.
Following this grant, Peck holds a total of 65,578.8067 phantom stock units directly under the plan. The filing does not reflect an open-market stock purchase or sale, but rather a non-market, cash-settled compensation award linked to Zoetis’s stock performance.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 26.1975 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. This compensation award increases her total phantom stock unit balance to 6,035.7462 units, whose value is tied to Zoetis common stock plus a small cash-equivalent component.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Financial Officer Joseph Wetteny received a grant of 873.9476 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component.
The units are cash-settled after his separation from service rather than delivering actual shares. Following this award, Wetteny holds a total of 9,792.3028 phantom stock units, notionally referencing 293.9359 shares of Zoetis common stock. This filing reflects routine compensation, not an open-market stock purchase or sale.
Zoetis Inc. Executive Vice President Keith Sarbaugh received a grant of phantom stock units as compensation. On this date, he acquired 230.7598 phantom stock units at a reference value of $39.64 per unit, bringing his total phantom stock unit balance to 2105.1927. Each phantom stock unit tracks the value of Zoetis common stock plus a small portion of cash-equivalent investments, and will be settled in cash after his separation from service.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity involving restricted stock units. On March 31, 2026, 1,528.0167 restricted stock units vested and were settled into 1,528 shares of Zoetis common stock, reflecting an exercise or conversion of derivative securities.
To cover tax obligations related to this vesting, 524 common shares were withheld at a price of $118.21 per share, classified as a tax-withholding disposition rather than an open-market sale. After these transactions, Sarbaugh directly held 3,346 shares of Zoetis common stock, along with remaining restricted stock units representing 2,674, 773 and 120 underlying common shares that will vest over future anniversaries if service conditions are met.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller received a grant of 669.3367 Phantom Stock Units tied to Zoetis common stock. These units were awarded at a reference value of $38.2000 per unit under the Zoetis Supplemental Savings Plan and are settled in cash after she leaves the company.
Following this award, Fuller holds a total of 1247.3931 Phantom Stock Units. Each unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of each unit’s value, so the unit value tracks the Zoetis share price and these cash-equivalent holdings.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny received a grant of 2,114.7557 phantom stock units on Zoetis common stock. The award was made at a reference value of $38.20 per unit under the Zoetis Supplemental Savings Plan.
Following this grant, Wetteny holds a total of 8,918.3552 phantom stock units. Each phantom stock unit tracks the market value of Zoetis common stock plus a small portion of cash-equivalent investments, and is settled in cash after his separation from service. The award currently corresponds to 712.6923 underlying shares of Zoetis common stock.
Zoetis Inc. Chief Executive Officer Kristin C. Peck received a grant of 4,391.2607 Phantom Stock Units at a reference price of $38.20 per unit. Following this award, she holds a total of 62,802.0367 Phantom Stock Units.
Each Phantom Stock Unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of the unit’s total value. These units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after her separation from service.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 641.7440 phantom stock units on Zoetis common stock at a reference value of $38.2000 per unit. Following this award, she holds a total of 6009.5487 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. These units are settled in cash after her separation from service and may be reallocated among plan investment funds subject to Zoetis’ transfer rules.
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received a grant of 219.9529 phantom stock units on Zoetis common stock. The award, valued using a reference price of $38.20 per unit, increased his holdings to 496.9909 phantom stock units, representing an economic interest tied to Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of the unit’s total value. These units are settled in cash after Esch’s separation from service, with 74.1262 underlying common shares linked to this particular grant.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 593.1735 Phantom Stock Units on Zoetis common stock, valued at $38.20 per unit. Each unit represents a fraction of a phantom share plus cash-equivalent investments, referencing Zoetis’ market value.
The grant corresponds to 199.9050 underlying shares of common stock, bringing the executive’s total Phantom Stock Units to 2,245.8327. These units, acquired under the Zoetis Supplemental Savings Plan, are cash-settled after separation from service and may be reallocated among investment funds subject to Zoetis’ transfer limits.
Zoetis Inc. Executive Vice President Keith Sarbaugh received a grant of 626.6723 phantom stock units on Zoetis common stock. Each phantom stock unit was valued at $38.20 and corresponds to 211.1944 underlying shares of common stock. Following this grant, his phantom stock unit balance is 1,874.4329 units. These units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after his separation from service, with value tied to Zoetis’ share price and a small portion in cash-equivalent investments.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 1,266.4405 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and units are settled in cash after separation from service.
The grant represents an economic interest equivalent to 426.8022 shares of Zoetis common stock, with a reference value of $38.2000 per phantom stock unit. Following this award, Lagano holds a total of 30,081.5721 phantom stock units, which remain subject to plan transfer and investment rules.
Zoetis Inc. director Mark Stetter reported receiving a grant of 215.5358 phantom stock units linked to Zoetis common stock. These units were acquired under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan as a deferral of his cash retainer fees into the Zoetis stock fund, including dividend equivalents. Each phantom stock unit represents one share of Zoetis common stock but will be settled in cash after his separation from service, so this is a compensation and deferral event rather than an open-market stock purchase or sale.
Zoetis Inc. director Gregory Norden reported a bona fide gift of 1,213 shares of Zoetis common stock on March 9, 2026. The shares were transferred to a trust for which he serves as trustee. Following this transfer, he holds Zoetis shares indirectly through personal and family trusts.
Zoetis Inc. director Michael B. McCallister reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, he exercised RSUs covering 1,619.3325 units at a price of $0.00 per unit, receiving 1,619 common shares. A separate entry shows 413 common shares transferred to Zoetis in exchange for cash based on the $127.28 closing share price on the vesting date. After these transactions, he directly held 1,209 common shares and 1,936 RSUs, with additional indirect holdings of 21,524 and 6,160 common shares held by family trusts.
Zoetis Inc. director Gregory Norden reported equity award activity involving restricted stock units (RSUs) and common shares. He exercised or converted 1,619.3325 RSUs, resulting in the acquisition of 1,619 common shares of Zoetis stock at a stated price of $0.00 per share, reflecting settlement of equity awards rather than an open-market purchase.
As part of the same event, 406 common shares were disposed of back to Zoetis in exchange for cash based on the closing share price of $127.28 per share on the vesting date, typically to cover obligations such as taxes. After these transactions, Norden directly held 1,213 common shares and 1,936 RSUs, and also had indirect ownership through a personal trust and separate trusts for his daughter and son, which together hold several thousand additional Zoetis common shares.
Zoetis Inc. director Vanessa Broadhurst reported equity compensation activity involving restricted stock units (RSUs) and common shares. On February 19, 2026, RSUs covering about 1,619 shares were exercised and converted into 1,619 shares of Zoetis common stock at a price of $0.00 per share. A separate transaction involving 517 common shares at $127.28 per share was reported as an other acquisition or disposition, with a footnote explaining these shares were transferred back to Zoetis in exchange for cash based on the closing share price on the vesting date. After these movements, she directly holds 3,920 shares of Zoetis common stock and 1,936 RSUs that each represent a contingent right to receive one share of common stock, generally vesting on the first anniversary of the grant date if service conditions are met.
Zoetis Inc. Executive Vice President Julie Fuller reported equity award activity tied to restricted stock units (RSUs). On February 19, 2026, RSUs converted into 750 shares of common stock at a stated price of $0.0000 per share, reflecting vesting and settlement of RSUs. On the same date, 290 common shares were disposed of at $127.2800 per share to cover tax obligations through a tax-withholding disposition. Footnotes explain that each RSU represents a right to receive one Zoetis common share, with one-third of each RSU grant generally vesting on each of the first, second, and third anniversaries of the grant dates, subject to continued service and certain earlier vesting events.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported equity compensation activity involving restricted stock units (RSUs) and common shares on February 19, 2026. RSUs representing 2,050.6517 units were exercised and converted, resulting in the acquisition of 2,050 common shares at a stated price of $0.00 per share as part of vesting and settlement.
To satisfy tax obligations tied to this vesting, 703 common shares were disposed of at $127.28 per share through tax withholding. After these transactions, Wetteny directly owned 22,113 shares of Zoetis common stock. He also held outstanding RSU awards that, after the reported activity, totaled 8,605 RSUs and 1,389 RSUs under separate grants, each generally vesting in one‑third increments on the first, second, and third anniversaries of their respective grant dates, subject to continued service and certain earlier‑vesting events.
Zoetis Inc. reports that Chief Executive Officer Kristin C. Peck acquired 7,354 shares of common stock on February 19, 2026 through the vesting and settlement of restricted stock units (RSUs), delivered at a $0.00 exercise price.
On the same date, 3,623 of those shares were withheld by the company at $127.28 per share to satisfy tax obligations associated with the RSU vesting. After these transactions, she directly holds 105,068 shares of Zoetis common stock and 48,336 RSUs, in addition to 833.6435 common-stock equivalents held indirectly in the Zoetis Savings Plan. Footnotes state that each RSU represents one share and that RSU grants under the Zoetis Amended and Restated 2013 Equity and Incentive Plan vest in three equal annual installments, subject to continued service.
Zoetis Inc. Executive Vice President Nicholas Ashton reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, he acquired 750 shares of Zoetis common stock at $0.0000 per share through the exercise and settlement of RSUs, with 2,214 common shares held directly after this step.
On the same date, 392 common shares at $127.2800 per share were disposed of to satisfy tax withholding obligations related to the vesting event, leaving 1,822 common shares held directly. Footnotes explain that each RSU converts into one Zoetis common share and vests in three annual installments following the original grant dates, subject to continued service and certain specified events.
Zoetis Inc. director Gavin Hattersley reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, 2026, RSUs covering 1,619.3325 units were exercised and converted into 1,619 common shares of Zoetis common stock at a stated price of $0.00 per share.
Following this conversion, Hattersley directly held 3,835 common shares, then disposed of 481 shares back to Zoetis in exchange for cash based on the closing share price of $127.28 per share, leaving 3,354 common shares held directly. The filing also shows a holding of 1,936 RSUs granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, each RSU representing a contingent right to receive one Zoetis common share upon vesting on its stated first-anniversary dates, subject to continued service and certain early vesting conditions.
Zoetis Inc. Executive Vice President Roxanne Lagano reported equity award activity involving restricted stock units and common shares. On February 19, 2026, she acquired 750.4257 restricted stock units through an exercise or conversion, resulting in 1,500 restricted stock units directly held after the transaction.
On the same date, she acquired 750 shares of Zoetis common stock upon vesting and settlement of restricted stock units, bringing her directly held common stock to 15,890 shares before tax withholding. To satisfy tax obligations, 258 shares of common stock were disposed of at $127.28 per share in a tax-withholding transaction, leaving 15,632 common shares held directly.
In addition to common shares, Lagano holds 3,664 restricted stock units and 545 restricted stock units from separate awards, each RSU representing a contingent right to receive one share of Zoetis common stock, with vesting generally in one-third installments on the first, second and third anniversaries of the applicable grant dates. She also indirectly holds 833.684 common stock equivalents through the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2025.
Zoetis Inc. Executive Vice President Kevin Esch reported equity transactions tied to his compensation. On February 19, 2026, restricted stock units were exercised into 102 shares of Zoetis common stock at a stated price of $0.00 per share, reflecting vesting of RSUs. To cover tax obligations, 35 shares of common stock were disposed of at $127.28 per share through share withholding, a non‑open‑market transaction.
Following these transactions, Esch directly held 394 shares of Zoetis common stock and several blocks of RSUs, including 4,026, 775.5724 and 44 RSUs that each represent a contingent right to receive one share upon vesting. Footnotes explain that most RSU awards vest in three equal annual installments on the first, second and third anniversaries of their grant dates, subject to his continued service and certain earlier‑vesting events. He also indirectly held 122.9323 common stock equivalents through the Zoetis Savings Plan (401(k)) as of December 31, 2025.
Zoetis Inc. Executive Vice President Jamie Brannan reported equity-related transactions on February 19, 2026. Brannan acquired 1,204.0741 restricted stock units through an exercise or conversion and received 1,204 shares of common stock upon vesting and settlement of RSUs, each representing one Zoetis share.
To cover tax obligations, 566 common shares were disposed of at $127.28 per share as a tax-withholding transaction, not an open-market sale. Following these transactions, Brannan directly held 3,290 common shares, plus additional RSU holdings and 445 common stock equivalents indirectly through the UK Share Ownership Plan.